The Congressional Black Caucus Foundation Has a New Corporate Megadonor
Amazon donated $1.7 million to the group last year as it faced allegations of illegal anti-union work.
Influence
Page 4
House Democrats’ New Anti-Progressive PAC is Funded by Corporate Lobbyists and PACs
The group will spend money to protect incumbent Democrats in safe districts against progressive primary challengers.
Manchin Raked in Record Q4 Donations While Killing Build Back Better Act
Sen. Joe Manchin (D-W.V.) received PAC donations from the fossil fuel, finance, and insurance industries in a record fourth quarter haul while killing the Democrats' signature bill.
Biden’s Million-Dollar Inaugural Donors Lobbied Against His Agenda
The Business Roundtable increased its lobbying spending last year by 70% over the previous year as its members pushed to pass the infrastructure bill first and kill the Build Back Better Act.
Corporate Consultants Voted for New Lobbyists on the DNC
Executives at well-connected corporate consultancies voted to approve DNC Chair Jaime Harrison's slate of "at-large" members, which included several new corporate lobbyists.
Reps Bought Pipeline Stocks Before Passing the Infrastructure Bill
While Congress considered infrastructure and climate legislation last year, reps kept up a stream of trades in oil and gas pipeline company stocks.
Lobbyists Kept Donating to GOP Election Objectors After Companies Cut off PACs
Many Hill lobbyists opted not to follow their employers' PAC policy and donated to the 147 Republican election objectors in Congress.
At Least 100 House Members Are Invested in Fossil Fuels
Reps among the top oil and gas investors in Congress bought more shares in pipeline companies as the House moved to pass the bipartisan infrastructure bill.
Manchin’s PAC Raked In Corporate Donations Just Before He Axed Build Back Better
Donations came from corporations that would likely have been impacted by the bill’s proposals.
Senators Against Generic Covid-19 Vaccines Have Gotten 2x Pharma Cash
A group of Republican senators sought to block U.S. support for an IP waiver for Covid-19 vaccines, a proposal that is strongly opposed by the pharmaceutical industry.